Evidence map›Paper›PMID 11687464›Full record

ArticleClinical and diagnostic laboratory immunology2001

Modulation of Mycobacterium bovis-specific responses of bovine peripheral blood mononuclear cells by 1,25-dihydroxyvitamin D(3).

W R Waters, B J Nonnecke, T E Rahner, M V Palmer, D L Whipple, R L Horst

Open access · diamondAbstract read
In one paragraph

Article in Clinical and diagnostic laboratory immunology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Prevalence ofFrontiers in veterinary science · 2024
    Pooled it
  2. Article
  3. Bovine Immunity and Vitamin DMicroorganisms · 2022
    Review
  4. Effects of 1,25-Dihydroxyvitamin DFrontiers in veterinary science · 2022
    Article
  5. Review
  6. Exogenous Vitamin DFrontiers in cellular and infection microbiology · 2021
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. 1,25-dihydroxyvitamin D3 and development of tuberculosis in cattle.Clinical and diagnostic laboratory immunology · 2003
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

W R WatersBacterial Diseases of Livestock Research Unit, National Animal Disease Center, Agricultural Research Service, United States Department of Agriculture, Ames, Iowa 50010-0070, USA. rwaters@nadc.ars.usda.gov
B J Nonnecke
T E Rahner
M V Palmer
D L Whipple
R L Horst
Ministry of Livestock and Fisheries · TZNational Animal Disease Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Historically, administration of vitamin D has been considered beneficial in the treatment of tuberculosis. The interaction of this vitamin [i.e., 1,25-dihdroxyvitamin D(3) [1,25(OH)(2)D(3)]] with the antitubercular immune response, however, is not clear. In the present study, in vitro recall responses of peripheral blood mononuclear cells (PBMC) from cattle infected with Mycobacterium bovis were used to study the immune-modulatory effects of 1,25(OH)(2)D(3) on M. bovis-specific responses in vitro. Addition of 1 or 10 nM 1,25(OH)(2)D(3) inhibited M. bovis-specific proliferative responses of PBMC from M. bovis-infected cattle, affecting predominantly the CD4(+) cell subset. In addition, 1,25(OH)(2)D(3) inhibited M. bovis-specific gamma interferon (IFN-gamma) production yet enhanced M. bovis-specific nitric oxide (NO) production. Lymphocyte apoptosis, measured by flow cytometry using annexin-V staining, was diminished by addition of 1,25(OH)(2)D(3) to PBMC cultures. These findings support the current hypothesis that 1,25(OH)(2)D(3) enhances mycobacterial killing by increasing NO production, a potent antimicrobial mechanism of activated macrophages, and suggest that 1,25(OH)(2)D(3) limits host damage by decreasing M. bovis-induced IFN-gamma production.

Indexed as

AnimalsApoptosisCalcitriolCalcium Channel AgonistsCattleCell DivisionEpitopesFemaleInterferon-gammaLeukocytes, MononuclearMaleMycobacterium bovisNitric OxideTuberculosis, BovineCalcitriolCalcium Channel AgonistsEpitopesInterferon-gammaNitric Oxide

Identifiers

PMID11687464
PMCPMC96250
OpenAlexW2125146117

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.